| scholarly article | Q13442814 |
| P2093 | author name string | L Wong | |
| S L Friedman | |||
| R J Johnson | |||
| G Yamasaki | |||
| P2860 | cites work | Primary structure of human ribosomal protein S14 and the gene that encodes it | Q24299857 |
| Two different subunits associate to create isoform-specific platelet-derived growth factor receptors | Q24307511 | ||
| Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
| Isolation and characterization of the alpha platelet-derived growth factor receptor from rat olfactory epithelium | Q28569574 | ||
| Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: evidence for more than one receptor class | Q33573916 | ||
| Two peptides related to platelet-derived growth factor are present in human wound fluid. | Q33861333 | ||
| Tissue localization of beta receptors for platelet-derived growth factor and platelet-derived growth factor B chain during wound repair in humans | Q33899101 | ||
| Nucleotide sequence of bacteriophage lambda DNA. | Q34055022 | ||
| Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo | Q34263631 | ||
| Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors | Q34580643 | ||
| Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells | Q34580695 | ||
| Induction of platelet-derived growth factor receptor expression in smooth muscle cells and fibroblasts upon tissue culturing. | Q36219663 | ||
| PDGF ligand and receptor gene expression during repair of arterial injury | Q36223935 | ||
| Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat | Q37557669 | ||
| Carbon tetrachloride hepatotoxicity: an example of free radical-mediated injury | Q38027603 | ||
| Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies | Q40911465 | ||
| Macrophage and perisinusoidal cell kinetics in acute liver injury | Q41110340 | ||
| Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture | Q41122442 | ||
| Retinoic acid and transforming growth factor β differentially inhibit platelet-derived-growth-factor-induced Ito-cell activation | Q42070235 | ||
| Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat | Q42119681 | ||
| Early alcoholic liver injury: changes of the Disse space in acinar zone 3. | Q42437370 | ||
| In vivo responses of macrophages and perisinusoidal cells to cholestatic liver injury. | Q42755303 | ||
| Modulation of platelet-derived growth factor receptor function in BP3T3, a chemically transformed BALB/c-3T3 cell line. | Q42797846 | ||
| Differential expression of platelet-derived growth factor α- and β-receptors on fat-storing cells and endothelial cells of rat liver | Q43736383 | ||
| Platelet-derived growth factor receptors in the kidney--upregulated expression in inflammation. | Q44162275 | ||
| Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix | Q46068321 | ||
| Modulation of transforming growth factor beta receptors of rat lipocytes during the hepatic wound healing response. Enhanced binding and reduced gene expression accompany cellular activation in culture and in vivo. | Q46591125 | ||
| Immunohistochemical detection of proliferating lipocytes in regenerating rat liver. | Q50882087 | ||
| High yield micronodular cirrhosis in the rat. | Q51858034 | ||
| In situ hybridization for procollagen types I, III and IV mRNA in normal and fibrotic rat liver: evidence for predominant expression in nonparenchymal liver cells. | Q53038196 | ||
| Importance of PDGF receptor expression in accelerated atherosclerosis-chronic rejection | Q57352002 | ||
| INDUCTION OF B-TYPE RECEPTORS FOR PLATELET-DERIVED GROWTH FACTOR IN VASCULAR INFLAMMATION: POSSIBLE IMPLICATIONS FOR DEVELOPMENT OF VASCULAR PROLIFERATIVE LESIONS | Q57352240 | ||
| Expression of the gene of the alpha-smooth muscle-actin isoform in rat liver and in rat fat-storing (ITO) cells | Q67683697 | ||
| A homologue of platelet-derived growth factor produced by rat alveolar macrophages | Q68130186 | ||
| Cell population kinetics of Kupffer cells during the onset of fibrosis in rat liver by chronic carbon tetrachloride administration | Q68276230 | ||
| Differential effects of interleukin-1 alpha, tumor necrosis factor alpha, and transforming growth factor beta 1 on cell proliferation and collagen formation by cultured fat-storing cells | Q69737804 | ||
| Liver fat storing cell proliferation is stimulated by epidermal growth factor/transforming growth factor alpha and inhibited by transforming growth factor beta | Q69742276 | ||
| Mitogenic signals for platelet-derived growth factor isoforms in liver fat-storing cells | Q70116895 | ||
| Tissue distribution, quantitation and proliferation kinetics of fat-storing cells in carbon tetrachloride-injured rat liver | Q70188762 | ||
| The role of fat-storing cells in Disse space fibrogenesis in alcoholic liver disease | Q71764404 | ||
| Expression of platelet-derived growth factor in a model of acute liver injury | Q72271873 | ||
| Perisinusoidal fat-storing cells are the main vitamin A storage sites in rat liver | Q93614712 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 1563-1569 | |
| P577 | publication date | 1994-10-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture | |
| P478 | volume | 94 |
| Q28569215 | A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis |
| Q33968080 | A transgenic model for conditional induction and rescue of portal hypertension reveals a role of VEGF-mediated regulation of sinusoidal fenestrations |
| Q36384024 | Actions of Huangqi decoction against rat liver fibrosis: a gene expression profiling analysis |
| Q48242025 | Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis. |
| Q37170189 | Activation of peroxisome proliferator-activated receptor-gamma by curcumin blocks the signaling pathways for PDGF and EGF in hepatic stellate cells |
| Q35131124 | Activation of platelet-derived growth factor receptor alpha contributes to liver fibrosis |
| Q43884266 | Adenovirus-mediated gene transfer to nonparenchymal cells in normal and injured liver |
| Q37353099 | Advances in antifibrotic therapy |
| Q35025282 | Angiotensin II facilitates fibrogenic effect of TGF-β1 through enhancing the down-regulation of BAMBI caused by LPS: a new pro-fibrotic mechanism of angiotensin II. |
| Q39364109 | Anti-fibrotic activity and enhanced interleukin-6 production by hepatic stellate cells in response to imatinib mesylate |
| Q40068184 | Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats. |
| Q39291844 | Antifibrotic activity of sorafenib in experimental hepatic fibrosis: refinement of inhibitory targets, dosing, and window of efficacy in vivo |
| Q36419888 | BRD4 is a novel therapeutic target for liver fibrosis |
| Q49379771 | Baicalin inhibits PDGF-BB-induced hepatic stellate cell proliferation, apoptosis, invasion, migration and activation via the miR-3595/ACSL4 axis |
| Q44624720 | Carbenoxolone inhibits DNA synthesis and collagen gene expression in rat hepatic stellate cells in culture |
| Q28204945 | Characterization of human stellate cell activation-associated protein and its expression in human liver |
| Q26825671 | Chronic hepatitis C and liver fibrosis. |
| Q50492083 | Cilostazol attenuates hepatic stellate cell activation and protects mice against carbon tetrachloride-induced liver fibrosis. |
| Q42067728 | Conditional beta-catenin loss in mice promotes chemical hepatocarcinogenesis: role of oxidative stress and platelet-derived growth factor receptor alpha/phosphoinositide 3-kinase signaling. |
| Q28363500 | DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells |
| Q28584826 | Discoidin domain receptor 2 regulates fibroblast proliferation and migration through the extracellular matrix in association with transcriptional activation of matrix metalloproteinase-2 |
| Q47785420 | Dominant-negative soluble PDGF-beta receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis |
| Q92494590 | ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis |
| Q36883885 | Early genes induced in hepatic stellate cells during wound healing |
| Q42542594 | Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells |
| Q44437097 | Effect of protein kinase C activation and inhibition on rat hepatic stellate cell activation |
| Q47362892 | Effect of shear stress on the migration of hepatic stellate cells |
| Q46886393 | Effects of bile acids on biliary epithelial cell proliferation and portal fibroblast activation using rat liver slices |
| Q59353042 | Effects of simvastatin, pentoxifylline and spironolactone on hepatic fibrosis and portal hypertension in rats with bile duct ligation |
| Q36677553 | Epigallocatechin-3-gallate inhibits growth of activated hepatic stellate cells by enhancing the capacity of glutathione synthesis |
| Q36727057 | Essential Role of Matrix Metalloproteinases in Interleukin-1-induced Myofibroblastic Activation of Hepatic Stellate Cell in Collagen |
| Q34345987 | Experimental models of hepatocellular carcinoma |
| Q36689584 | Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) increases human hepatic stellate cell activation. |
| Q42049031 | Expression of cellular prion protein in activated hepatic stellate cells |
| Q78001290 | Expression of cyclins D1, D2 and E correlates with proliferation of rat stellate cells in culture |
| Q73572264 | Expression of platelet-derived growth factor and its receptor in livers of patients with chronic liver disease |
| Q42826980 | Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis |
| Q61763072 | Expression of platelet-derived growth factor in newly formed cholangiocytes during experimental biliary fibrosis in rats |
| Q47264700 | Food components with antifibrotic activity and implications in prevention of liver disease |
| Q37406655 | Galanin receptor 2 mediates antifibrogenic effects of galanin on hepatic stellate cells |
| Q46744355 | Glutathione regulation in rat hepatic stellate cells. Comparative studies in primary culture and in liver injury in vivo |
| Q98771721 | Hepatic Stellate Cells and Hepatocarcinogenesis |
| Q38930049 | Hepatic Stellate Cells in Liver Fibrosis and siRNA-Based Therapy |
| Q71498805 | Hepatic fibrogenesis |
| Q34269628 | Hepatic fibrosis. Pathogenesis and principles of therapy |
| Q37629675 | Hepatic inflammation and progressive liver fibrosis in chronic liver disease |
| Q43821781 | Hepatic stellate cell proliferation is an early platelet-derived growth factor-mediated cellular event in rat cholestatic liver injury |
| Q34387063 | Hepatic stellate cells and liver fibrosis |
| Q29616840 | Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver |
| Q45366886 | Hepatitis C virus core protein induces fibrogenic actions of hepatic stellate cells via toll-like receptor 2. |
| Q64275574 | High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway |
| Q45931088 | Human hepatic stellate cell isolation and characterization. |
| Q38333252 | Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. |
| Q33718285 | IGFBPrP1 induces liver fibrosis by inducing hepatic stellate cell activation and hepatocyte apoptosis via Smad2/3 signaling |
| Q26798033 | Identifying Novel Targets for Treatment of Liver Fibrosis: What Can We Learn from Injured Tissues which Heal Without a Scar? |
| Q77807999 | In vitro migratory potential of rat quiescent hepatic stellate cells and its augmentation by cell activation |
| Q55400995 | In vivo and in vitro interactions between human colon carcinoma cells and hepatic stellate cells. |
| Q47907153 | Increased Binding and Chemotactic Capacities of PDGF-BB on Fibroblasts in Radiation Pneumonitis |
| Q54935800 | Influence of amygdalin on PDG, IGF and PDGFR expression in HSC-T6 cells. |
| Q43875838 | Inhibition of rat liver fibrogenesis through noradrenergic antagonism |
| Q33780195 | Inhibitory effects of rapamycin on the different stages of hepatic fibrosis |
| Q31970467 | Inhibitory effects of the herbal medicine Sho-saiko-to (TJ-9) on cell proliferation and procollagen gene expressions in cultured rat hepatic stellate cells |
| Q33946587 | Integrins, myofibroblasts, and organ fibrosis |
| Q87669646 | Liver fibrosis |
| Q35068035 | Liver fibrosis -- from bench to bedside |
| Q22010594 | Mechanism of action and in vivo role of platelet-derived growth factor |
| Q29619336 | Mechanisms of hepatic fibrogenesis |
| Q37865859 | Mechanisms of hepatic fibrogenesis |
| Q39294420 | Mechanisms of hepatic stellate cell activation |
| Q28084572 | Membrane-to-Nucleus Signals and Epigenetic Mechanisms for Myofibroblastic Activation and Desmoplastic Stroma: Potential Therapeutic Targets for Liver Metastasis? |
| Q40892757 | Molecular mechanisms of hepatic fibrosis and principles of therapy |
| Q33907429 | Molecular mechanisms of liver fibrosis in HIV/HCV coinfection |
| Q77619568 | Molecular regulation of hepatic fibrogenesis |
| Q30495328 | Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF/TGF-beta signaling in hepatic stellate cells |
| Q54976874 | Niemann-Pick Type C2 Protein Regulates Free Cholesterol Accumulation and Influences Hepatic Stellate Cell Proliferation and Mitochondrial Respiration Function. |
| Q84021827 | Novel engineered targeted interferon-gamma blocks hepatic fibrogenesis in mice |
| Q42548596 | Novel insight into a platelet-derived growth factor-C/Smad3 axis in liver fibrosis. Focus on "Role of Smad3 in platelet-derived growth factor-C-induced liver fibrosis". |
| Q35622533 | Novel insights into the function and dynamics of extracellular matrix in liver fibrosis |
| Q90365064 | Nrf2 protects stellate cells from Smad-dependent cell activation |
| Q37037061 | Oxidative and nitrosative stress and fibrogenic response |
| Q42488577 | PDGF-mediated chemoattraction of hepatic stellate cells by bile duct segments in cholestatic liver injury |
| Q28085644 | PDGFRα in liver pathophysiology: emerging roles in development, regeneration, fibrosis, and cancer |
| Q49544674 | Pericytes: The Role of Multipotent Stem Cells in Vascular Maintenance and Regenerative Medicine |
| Q73308051 | Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells |
| Q90291175 | Plantamajoside exerts antifibrosis effects in the liver by inhibiting hepatic stellate cell activation |
| Q50876050 | Platelet-Derived Growth Factor Receptor α Contributes to Human Hepatic Stellate Cell Proliferation and Migration. |
| Q24556510 | Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma |
| Q42439505 | Platelet-derived growth factor isoform expression in carbon tetrachloride-induced chronic liver injury |
| Q33889261 | Platelet-derived growth factor receptor α in hepatocellular carcinoma is a prognostic marker independent of underlying liver cirrhosis |
| Q44636389 | Potent and selective inhibitors of platelet-derived growth factor receptor phosphorylation. 3. Replacement of quinazoline moiety and improvement of metabolic polymorphism of 4-[4-(N-substituted (thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazolin |
| Q44563596 | Potent and selective inhibitors of platelet-derived growth factor receptor phosphorylation. Part 4: structure-activity relationships for substituents on the quinazoline moiety of 4-[4-(N-substituted(thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinaz |
| Q50164237 | Precision-cut human liver slice cultures as an immunological platform. |
| Q35573937 | Primary biliary cirrhosis: the future |
| Q42488195 | Protective effect of Spirulina platensis against cell damage and apoptosis in hepatic tissue caused by high fat diet |
| Q36921566 | Quinazoline derivatives: synthesis and bioactivities |
| Q28569125 | RNA interference targeting the platelet-derived growth factor receptor beta subunit ameliorates experimental hepatic fibrosis in rats |
| Q43878348 | Rearrangement of the cytoskeletal network induced by platelet-derived growth factor in rat hepatic stellate cells: role of different intracellular signalling pathways |
| Q36472048 | Regulation of fibrosis by the immune system |
| Q53565626 | Retinoic acid signaling sensitizes hepatic stellate cells to NK cell killing via upregulation of NK cell activating ligand RAE1. |
| Q37355850 | Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies |
| Q36698776 | Role of Smad3 in platelet-derived growth factor-C-induced liver fibrosis |
| Q43586170 | Role of myofibroblasts in tumour encapsulation of hepatocellular carcinoma in haemochromatosis |
| Q38207013 | Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma |
| Q52575315 | STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity. |
| Q59795410 | Selective deletion of hepatocyte platelet-derived growth factor receptor α and development of liver fibrosis in mice |
| Q71846440 | Sp1 binding activity increases in activated Ito cells |
| Q27347907 | Stiffening hydrogels for investigating the dynamics of hepatic stellate cell mechanotransduction during myofibroblast activation |
| Q78228848 | Strong antiproliferative effects of baicalein in cultured rat hepatic stellate cells |
| Q37884986 | Structural requirements of heparin binding to Chlamydia trachomatis |
| Q53592062 | Sustained activation of Rac1 in hepatic stellate cells promotes liver injury and fibrosis in mice. |
| Q37705967 | TGF-β Mediated Crosstalk Between Malignant Hepatocyte and Tumor Microenvironment in Hepatocellular Carcinoma |
| Q39977440 | Targeted inhibition of platelet-derived growth factor receptor-beta subunit in hepatic stellate cells ameliorates hepatic fibrosis in rats |
| Q35108259 | Targeted recombinant fusion proteins of IFNγ and mimetic IFNγ with PDGFβR bicyclic peptide inhibits liver fibrogenesis in vivo |
| Q42583288 | Targeting 15d-prostaglandin J2 to hepatic stellate cells: two options evaluated. |
| Q95270458 | Targeting Hepatic Stellate Cells for the Treatment of Liver Fibrosis by Natural Products: Is It the Dawning of a New Era? |
| Q30395463 | Targeting activated hepatic stellate cells (aHSCs) for liver fibrosis imaging |
| Q37374921 | Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs |
| Q44403700 | The Antioxidant (–)-Epigallocatechin-3-gallate Inhibits Rat Hepatic Stellate Cell Proliferation in Vitro by Blocking the Tyrosine Phosphorylation and Reducing the Gene Expression of Platelet-derived Growth Factor-β Receptor |
| Q64235995 | The Forkhead box F1 transcription factor inhibits collagen deposition and accumulation of myofibroblasts during liver fibrosis |
| Q34170449 | The cell and molecular biology of hepatic fibrogenesis. Clinical and therapeutic implications |
| Q38321523 | The importance of extracellular matrix for cell function and in vivo likeness. |
| Q79987571 | The interruption of the PDGF and EGF signaling pathways by curcumin stimulates gene expression of PPARgamma in rat activated hepatic stellate cell in vitro |
| Q40206078 | The oncofetal protein glypican-3 is a novel marker of hepatic progenitor/oval cells |
| Q42835446 | The preferential homing of a platelet derived growth factor receptor-recognizing macromolecule to fibroblast-like cells in fibrotic tissue |
| Q44383140 | The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo |
| Q41425182 | Therapeutic targeting of the PDGF and TGF-beta-signaling pathways in hepatic stellate cells by PTK787/ZK22258 |
| Q35046541 | Treatment of hepatic fibrosis: almost there |
| Q39391726 | Tricin inhibits proliferation of human hepatic stellate cells in vitro by blocking tyrosine phosphorylation of PDGF receptor and its signaling pathways |
| Q34985947 | Use of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects. |
| Q24319960 | Zf9, a Kruppel-like transcription factor up-regulated in vivo during early hepatic fibrosis |
| Q42165937 | β-PDGF receptor expressed by hepatic stellate cells regulates fibrosis in murine liver injury, but not carcinogenesis |
Search more.